Resultado da Busca
We are Haleon. We are a world-leading consumer health company with a clear purpose to deliver better everyday health with humanity. Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally.
- Careers
The Haleon Experience is about building something together....
- Who we are
The power of brands. We have nine large-scale multinational...
- Our Brands
Our leading brands are built on science, innovation and...
- Our Impact
As a leading global player in consumer health, Haleon is...
- Investors
Haleon has a strong portfolio of brands and is well...
- Strategy
Haleon does this by increasing condition awareness, building...
- Governance
At Haleon, we are committed to operating with strong...
- Where we operate
Nos marques appartiennent ou sont concédée(s) au groupe...
- Careers
28 de fev. de 2022 · A Haleon é o resultado do spin-off da GSK, que vai se concentrar em medicamentos prescritivos. A nova empresa tem mais de 100 produtos, incluindo Sensodyne, Eno, Advil e Centrum, e pretende crescer acima do mercado no Brasil.
- GSK Share Consolidation
- Disclaimer
- Expected Timetable of Principal Events
- GeneratedCaptionsTabForHeroSec
At the GSK General Meeting on 6 July 2022, alongside the demerger, GSK shareholders also approved the consolidation of GSK shares (the “GSK Share Consolidation”). The GSK Share Consolidation is expected to take place after the market closes today. It is expected that admission and dealings in the new GSK shares on the LSE will commence at 8.00 a.m....
GSK makes no representation or warranty as to the appropriateness, accuracy, completeness or reliability of the information in this announcement. This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dis...
The times and dates set out in the timetable below and throughout this announcement are indicative only and based on GSK’s current expectations and may be subject to change without further notice.
Haleon plc, the new consumer healthcare company, has been listed on the London Stock Exchange and the New York Stock Exchange. GSK shareholders have also approved the consolidation of GSK shares, which will take effect after the market closes on 18 July 2022.
22 de fev. de 2022 · Haleon is the name of the new company that will result from the proposed demerger of GSK's Consumer Healthcare business in mid-2022. Haleon will have a portfolio of global brands, including Sensodyne, Voltaren, Panadol and Centrum, and will be listed on the London Stock Exchange.
GSK plc (LSE/NYSE: GSK) today announced that, further to its announcement on 16 May 2024, GSK has agreed to sell 385,320,110 ordinary shares in Haleon plc (“Haleon”) at a price of 324 pence per share (the “Placing Shares”), raising gross proceeds of approximately £1,248m (the “Placing”). Following settlement of the Placing, GSK ...
Haleon é uma empresa que oferece produtos e soluções para saúde oral, VMS, alívio da dor, saúde digestiva e outros. Saiba mais sobre sua história, inovação, parcerias e compromisso com a inclusividade em saúde.
28 de fev. de 2022 · Haleon is the new consumer health company to be formed from the demerger of GSK's consumer healthcare business in July 2022. It has a portfolio of category-leading brands, a global footprint, and a strategy to deliver above-market growth and attractive returns.
